The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer

Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer

NCT03498326 ·Status: RECRUITING ·Phase: PHASE2

mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients

NCT04084496 ·Status: RECRUITING ·Phase: PHASE2

Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.

NCT04835064 ·Status: UNKNOWN ·Phase: PHASE3

Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)

NCT06427447 ·Status: RECRUITING ·Phase: PHASE3

Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer

NCT02635971 ·Status: UNKNOWN ·Phase: PHASE2

S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer

NCT02131493 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer

NCT05911217 ·Status: RECRUITING ·Phase: PHASE1

The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Determining the Prognosis of Pancreatic Ductal Adenocarcinoma

NCT06807112 ·Status: NOT_YET_RECRUITING

A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan

NCT04070313 ·Status: TERMINATED ·Phase: PHASE2

A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer

NCT06492941 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer

NCT03002831 ·Status: TERMINATED ·Phase: PHASE2

Organoid-Guided Adjuvant Chemotherapy for Pancreatic Cancer

NCT04931394 ·Status: UNKNOWN ·Phase: PHASE3

Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy

NCT00644618 ·Status: COMPLETED ·Phase: PHASE3

Adjuvant Pancreatic Therapy Guided by MRD

NCT06966440 ·Status: RECRUITING ·Phase: NA

Multimodal Therapy Impact on Pancreatic Cancer Survival

NCT06938906 ·Status: ACTIVE_NOT_RECRUITING

Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer

NCT04216758 ·Status: UNKNOWN ·Phase: PHASE2

Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer

NCT07302841 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer

NCT05840341 ·Status: RECRUITING ·Phase: PHASE3

EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer

NCT01834170 ·Status: COMPLETED ·Phase: PHASE1

Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer

NCT04324307 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)

NCT02461836 ·Status: UNKNOWN ·Phase: PHASE2

Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection

NCT02023021 ·Status: COMPLETED ·Phase: PHASE2

MRD in PAAD Adjuvant Therapy

NCT06867146 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma

NCT06229496 ·Status: RECRUITING ·Phase: PHASE1

Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients

NCT03278015 ·Status: UNKNOWN ·Phase: PHASE2